medigraphic.com
ISSN 1561-297X (Print)

2014, Number 1

<< Back Next >>

Rev Cubana Estomatol 2014; 51 (1)

Factors related to the occurrence and classification of radiation-induced oral mucositis

Stuart VHT, Campêlo SMG, de Medeiros NDR, Vieira PJ, Queiroga CGD, Vieira PMS

Language: Portugués
References: 21
Page: 71-79
PDF size: 150.87 Kb.


ABSTRACT

Introduction: oral mucositis is considered the most common acute complication resulting from head and neck antineoplastic therapy. It is characterized by erythema and mucosa edema, commonly followed by ulceration and peeling.
Objective: this study aimed to assess the factors related to the onset and grading of oral mucositis in patients undergoing radiotherapy for head and neck cancer.
Methods: a longitudinal study was conducted, comprising 22 patients with a diagnosis of head and neck malignancy undergoing radiotherapy. These patients were evaluated during 4 weeks and they were checked for the onset and grading of oral mucositis during antineoplastic treatment.
Results: according to coefficient ñ tests by Spearman, U Mann-Whitney and Kruskal-Wallis, oral mucositis developed in 95.45% of patients who underwent head and neck radiotherapy, with higher grading among smokers compared with those of non-smokers, with statistically significant difference (p = 0.034).
Conclusion: these results suggest that there was no association between age, alcohol consumption and patients' oral hygiene with the onset and grading of mucositis. Smokers were found to show higher grading of radiation-induced oral mucositis on its onset.


REFERENCES

  1. Emidio TCS, Maeda YC, Caldo-Teixeira AS, Puppin Rontani RM. Oral manifestations of leukemia and antineoplasic treatment-a literatura review (part I). Braz J Health. 2010;1(1):110-21.

  2. Simões CA, Castro JFL, Cazal C. Candida Oral como Fator Agravante da Mucosite Radioinduzida. Rev Bras Cancerol. 2011;57(1):23-9.

  3. Miller MM, Donald DV, Hagemann TM. Prevention and treatment of oral mucositis in children with cancer. J Pediatr Pharmacol Ther. 2012;17(4): 340-50.

  4. Radvansky LJ, Pace MB, Siddiqui A. Prevention and management of radiationinduced dermatitis, mucositis and xerostomia. Am J Health Syst Pharm. 2013;70(12):1025-32.

  5. Peterson DE, Bensadoun RJ, Roila F. Management of oral and Gastrointestinal mucositis: ESMO. Clinical Practice Guidelines, Annals of Oncology. 2010;21(Supp.5):261-5.

  6. Rugg T, Saunders MI, Dische S. Smoking and mucosal reactions to radiotherapy. Br J Radiol. 1990;63:554-6.

  7. World Health Organization. Handbook for reporting results of cancer treatment. Geneva, Switzerland: World Health Organisation; 1979.

  8. Lockhart PT, Clark J. Pretherapy dental status of pacients with malignant conditions of the head and neck. Oral Surg Oral Med Oral Pathol. 1994;77(3):236-41.

  9. Nicolatou-Galitis O, Kouloulias V, Sotiropoulou-Lountou A, Dardoufas K, Polychronopoulou A , Athanassiadou P, et al. Oral Mucositis, Pain and Xerostomia in 135 Head and Neck Cancer Patients Receiving Radiotherapy with or without Chemotherapy. Open Cancer J. 2011;4:7-17.

  10. Colley HE, Eves PC, Pinnock A, Thornhill MH, Murdoch C. Tissue engineered oral mucosa to study radiotherapy-induced oral mucositis. Int J Radiat Biol. 2013 Jun 26.

  11. Sonis ST. A biological approach to mucositis. J Support Oncol. 2004 Jan- Feb;2(1):21-32.

  12. Cardoso MFA, Novikoff S, Tresso A, Segreto RA, Cervantes O. Prevenção e controle das sequelas bucais em pacientes irradiados por tumores de cabeça e pescoço. Radiol Bras. 2005;38(2):107-15.

  13. Almeida PNM, Albuquerque RA, Roesler E, S APV. Avaliação epidemiológicoclínica da mucosite oral radioinduzida em pacientes com neoplasias malignas na região de cabeça e pescoço. Rev Odontol UNESP. 2009;38(4):211-6.

  14. Martins MD, Marques MM, Bussadori SK, Martins MA, Pavesi VC, Mesquita- Ferrari RA, et al. Comparative analysis between Chamomilla recutita and corticosteroids on wound healing. An in vitro and in vivo study. Phytother Res. 2009;23(2):274-8.

  15. Porock D. Factors influencing the severity of radiation skin and oral mucosal reactions: development of a conceptual framework. Eur J Cancer Care (Engl). 2002;11(1):33-3.

  16. Suresh AVS, Varma PP, Sinha S, Deepika S, Raman R, Srinivasan M, et al. Riskscoring system for predicting mucositis in patients of head and neck cancer receiving concurrent chemoradiotherapy (rssm-hn). J Cancer Res Ther. 2010;6(4):448-51.

  17. Alvarenga LM, Ruiz MT, Pavarino-Bertelli EC, Ruback MJC, Maniglia JV, Goloni- Bertollo EM. Avaliação epidemiologica de pacientes com câncer de cabeça e pescoço em um hospital universitário do noroeste do estado de São Paulo. Rev Bras Otorrinolaringol. 2008;74(1):68-3.

  18. Santos RCS, Dias RS, Giordani AJG, Segreto RAS, Segreto, HRC. Mucosite em pacientes portadores de câncer de cabeça e pescoço submetidos à radioquimioterapia. Rev Esc Enferm USP. 2011;45(6):1338-44.

  19. Elting LS, Cooksley CD, Chambers MS, Garden AS. Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies. Int J Radit Oncol Biol Phys. 2007;68(4):1110-20.

  20. Turesson I, Nyman J, Holmberg E, Odén A. Prognostic factors for acute and late skin reactions in radiotherapy patients. Int J Radit Oncol Biol Phys. 1996;36(5):1065-75.

  21. Schirmer EM, Ferrari A, Trindade LCT. Evolução da mucosite oral após intervenção nutricional em pacientes oncológicos no serviço de cuidados paliativos. Rev Dor. 2012;13(2):141-6.




2020     |     www.medigraphic.com